Home/Pipeline/AI for Specific Cardiomyopathies

AI for Specific Cardiomyopathies

Aortic Stenosis, Amyloidosis, etc.

Research/DevelopmentActive

Key Facts

Indication
Aortic Stenosis, Amyloidosis, etc.
Phase
Research/Development
Status
Active
Company

About Ligence

Ligence is a Zurich-based digital health company founded in 2019, focusing on AI-driven automation of echocardiography analysis. Its core platform, Ligence Heart™, is a certified, vendor-neutral software suite designed to integrate into clinical workflows, cut reporting time, and standardize measurements according to established cardiology guidelines. The company has achieved key regulatory milestones in the US and EU and is backed by published research in leading journals, positioning it to address significant inefficiencies in cardiac ultrasound diagnostics.

View full company profile

Therapeutic Areas